Rita M. Braziel, M.D.
- click here
The focus of Dr. Braziel's services include hematopathology, which comprise of bone marrow, lymph nodes, hemepath flow cytometry and hemepath molecular diagnostic cases. Her clinical areas of interest are all areas of diagnostic hematopathology and standardization of molecular diagnostic in hematopathology. Dr. Braziel currently serves as the director of Hematopathology at OHSU.
"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue,"
"Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms,"
"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma,"
"A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine- tositumomab,"
"Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.,"